NeuroRx, Inc.

Industry · 9 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcra Treatment Resistant Depression	Phase 2 / Phase 3	2026-03-01
Unknown	NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis Urinary Tract Infections, Pyelonephritis	Phase 2	2024-03-31
Completed	NRX-101 for Bipolar Depression With Subacute Suicidal Ideation Bipolar Depression, Suicidal Ideation and Behavior	Phase 2 / Phase 3	2022-05-12
Withdrawn	Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine. COVID-19	Phase 2 / Phase 3	2021-09-30
Unknown	NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation Bipolar Depression, Suicidal Ideation	Phase 3	2019-12-01
Unknown	NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression Bipolar Depression, Suicidal Ideation	Phase 3	2019-06-25
Completed	NRX101 Glx Biomarker Validation Study Bipolar Depression, Suicidal Ideation	Phase 2 / Phase 3	2018-11-01
Completed	Sequential Therapy for the Treatment of Severe Bipolar Depression. Bipolar Depression, Suicidal Ideas, Suicidal Ideation	Phase 2	2018-01-15
Available	NRX-101 Expanded Access Bipolar Depression, Bipolar Affective Disorder	—	—